SAMRAT PHARMACHEM
Back to Cashflow Statement
|
SAMRAT PHARMACHEM Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-10 Cr | ₹9.41 Cr | ₹-9.44 Cr | ₹17 Cr | ₹4.80 Cr |
What is the latest Cash Flow from Operating Activities ratio of SAMRAT PHARMACHEM ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-10 Cr |
| Mar2024 | ₹9.41 Cr |
| Mar2023 | ₹-9.44 Cr |
| Mar2022 | ₹17 Cr |
| Mar2021 | ₹4.80 Cr |
How is Cash Flow from Operating Activities of SAMRAT PHARMACHEM Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-10 Cr | Negative | |
| Mar2024 | ₹9.41 Cr | Positive | |
| Mar2023 | ₹-9.44 Cr | Negative | |
| Mar2022 | ₹17 Cr | 264.19 | |
| Mar2021 | ₹4.80 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SAMRAT PHARMACHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAMRAT PHARMACHEM | ₹62.6 Cr | -4% | -12.4% | -43.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,329.0 Cr | -0.2% | -6.3% | -8.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,674.0 Cr | 3.3% | -3.4% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,891.0 Cr | -0.7% | 3.8% | 26.3% | Stock Analytics | |
| CIPLA | ₹107,292.0 Cr | -3% | -11.8% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,184.0 Cr | 6% | -3.5% | -4.3% | Stock Analytics | |
SAMRAT PHARMACHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAMRAT PHARMACHEM | -4% |
-12.4% |
-43.4% |
| SENSEX | 0.2% |
-3.6% |
8.6% |
You may also like the below Video Courses